Search Results - Yuanliang Yan

Immune cell death-related lncRNA signature as a predictive factor of clinical outcomes and immune checkpoints in gastric cancer by Zeyu Zhang, Duntao Su, Abhimanyu Thakur, Kui Zhang, Fada Xia, Yuanliang Yan, Yuanliang Yan

Connect to this object online.

Babaodan overcomes cisplatin resistance in cholangiocarcinoma via inhibiting YAP1 by Jiong Li, Xiangjun Ma, Faying Xu, Yuanliang Yan, Weiqing Chen

Connect to this object online.

Tabersonine enhances cisplatin sensitivity by modulating Aurora kinase A and suppressing epithelial-mesenchymal transition in triple-negative breast cancer by Xi Chen, Yuanliang Yan, Yuanhong Liu, Qiaoli Yi, Zhijie Xu

Connect to this object online.

The antibiotic drug tigecycline: A focus on its promising anticancer properties by Zhijie Xu, Zhijie Xu, Yuanliang Yan, Zhi Li, Long Qian, Zhicheng Gong

Connect to this object online.

Applying artificial intelligence for cancer immunotherapy by Zhijie Xu, Xiang Wang, Shuangshuang Zeng, Xinxin Ren, Yuanliang Yan, Zhicheng Gong

Connect to this object online.

Current understanding of plant-derived exosome-like nanoparticles in regulating the inflammatory response and immune system microenvironment by Qiaoli Yi, Zhijie Xu, Abhimanyu Thakur, Kui Zhang, Qiuju Liang, Yuanhong Liu, Yuanliang Yan

Connect to this object online.

SCD1 Confers Temozolomide Resistance to Human Glioma Cells via the Akt/GSK3β/β-Catenin Signaling Axis by Shuang Dai, Shuang Dai, Shuang Dai, Yuanliang Yan, Yuanliang Yan, Zhijie Xu, Zhijie Xu, Zhijie Xu, Shuangshuang Zeng, Shuangshuang Zeng, Long Qian, Long Qian, Lei Huo, Xuejun Li, Lunquan Sun, Zhicheng Gong, Zhicheng Gong

Connect to this object online.

Corrigendum: SCD1 Confers Temozolomide Resistance to Human Glioma Cells Via the Akt/GSK3β/β-Catenin Signaling Axis by Shuang Dai, Shuang Dai, Shuang Dai, Yuanliang Yan, Yuanliang Yan, Zhijie Xu, Zhijie Xu, Zhijie Xu, Shuangshuang Zeng, Shuangshuang Zeng, Long Qian, Long Qian, Lei Huo, Xuejun Li, Lunquan Sun, Zhicheng Gong, Zhicheng Gong

Connect to this object online.

Unraveling the significance of exosomal circRNAs in cancer therapeutic resistance by Fanhua Kang, Yuanliang Yan, Yuanhong Liu, Qiuju Liang, Qiuju Liang, Zhijie Xu, Wei Zhu, Abhimanyu Thakur

Connect to this object online.

Nanomaterial-encapsulated STING agonists for immune modulation in cancer therapy by Xi Chen, Zhijie Xu, Tongfei Li, Abhimanyu Thakur, Yu Wen, Kui Zhang, Yuanhong Liu, Qiuju Liang, Wangrui Liu, Jiang-Jiang Qin, Yuanliang Yan

Connect to this object online.

Aberrant Expression of ADARB1 Facilitates Temozolomide Chemoresistance and Immune Infiltration in Glioblastoma by Can Lu, Xi Chen, Yuanliang Yan, Xinxin Ren, Xiang Wang, Bi Peng, Yuan Cai, Qiuju Liang, Zhijie Xu, Zhijie Xu, Zhijie Xu, Jinwu Peng, Jinwu Peng

Connect to this object online.

Non-coding RNAs: The recently accentuated molecules in the regulation of cell autophagy for ovarian cancer pathogenesis and therapeutic response by Bi Peng, Jing Li, Yuanliang Yan, Yuanhong Liu, Qiuju Liang, Qiuju Liang, Wei Liu, Wei Liu, Abhimanyu Thakur, Kui Zhang, Zhijie Xu, Jian Wang, Fan Zhang

Connect to this object online.

Alantolactone: A Natural Plant Extract as a Potential Therapeutic Agent for Cancer by Yuan Cai, Kewa Gao, Bi Peng, Zhijie Xu, Zhijie Xu, Zhijie Xu, Jinwu Peng, Jinwu Peng, Juanni Li, Xi Chen, Xi Chen, Shuangshuang Zeng, Shuangshuang Zeng, Kuan Hu, Yuanliang Yan

Connect to this object online.